Bivalirudin Injection, Solution
Product Images NDC 70511-142

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bivalirudin (NDC 70511-142). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Maia Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bivalirudin-spl-10packcarton (Bivalirudin Spl 10packcarton)

Bivalirudin-spl-10packcarton (Bivalirudin Spl 10packcarton)
This appears to be a medication label for Bivalirudin Injection, a prescription drug for intravenous use only. The medication is Ready To Use and should not be diluted. It is recommended to store the vials in the refrigerator at 2° to 8°C but can be stored at room temperature for up to 72 hours. The label provides information on the contents of the injection and its usage. The manufacturer is MAIA Pharmaceuticals, Inc. located in Princeton, NJ.*
FDA Label Image

Bivalirudin-spl-chemical-structure (Bivalirudin Spl Chemical Structure)

FDA Label Image

Bivalirudin-spl-monocarton (Bivalirudin Spl Monocarton)

Bivalirudin-spl-monocarton (Bivalirudin Spl Monocarton)
This is a description of Bivalirudin Injection, a medication for intravenous use only. Each milliliter contains 5 mg of bivalirudin. It is pre-packaged in single-dose vials and should not be diluted. The recommended storage temperature is between 2° to 8°C. Once removed from the refrigerator, it can be stored at room temperature for up to 72 hours. The medication is manufactured by MAIA Pharmaceuticals, Inc. located in Princeton, NJ.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.